Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

NEXT SCIENCE LTD NEXT SCIENCE
Updated on 07 Aug 2020 (End of trading day)
Last (AUD): 1.265 Change: -0.005 High: 1.310 Remarks: -
Change (%): -0.39 Low: 1.260
Open 1.275 Yesterday's Close 1.2699999999999998
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 92,707 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.11375 Trailing EPS (AUD) e -0.11375 NAV (AUD) b 0.1517
PE a - Trailing PE f - Price / NAV b 8.3388
Dividend (AUD) d - Cash In Hand (AUD) g 0.1325 Issued & Paid-up Shares c 181,547,000
Dividend Yield (%) d - Price / Cash In Hand g 9.547 Treasury Shares h -
Beta - 75 Daysi 0.903 R-Squared - 75 Days(%)i 2.22 Market Cap (M) 229.657
Beta - 500 Daysi 1.144 R-Squared - 500 Days (%)i 0.04 Enterprise Value (M) 206.286
Piotroski F Score 1 Exchange Code NXS Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 87.69 Free Float (%) 33.5
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 02 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 18 Apr 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference NEXT SCIENCE LTD ASX 229.657 - - 8.3388 -
Industry Biotechnology ASX 3,570.681 56.022 50.760 13.4357 0.912
Local Peer CSL ASX 124,495.695 46.403 42.977 14.3952 0.967
Local Peer MESOBLAST LTD ASX 2,556.123 - - 3.2049 -
Local Peer POLYNOVO LIMITED ASX 1,461.004 - - 59.5687 -
Local Peer TELIX PHARMACEUTIC ASX 344.094 - - 4.9094 -
Local Peer IMUGENE LIMITED ASX 250.084 - - 3.8356 -
Local Peer NEUREN PHARMACEUTICALS LTD ASX 152.890 - - 11.0450 -
Local Peer ANTEOTECH LIMITED ASX 98.138 - - 31.0526 -
Local Peer MEMPHASYS LTD ASX 98.017 - - 9.8485 -
Local Peer IMMUTEP LTD ASX 90.212 - - 3.2174 -
Local Peer INVEX THERAPEUTICS LTD NPV ASX 77.784 - - - -
Local Peer GENETIC TECHNOLOGIES ASX 74.356 - - 30.0000 -
Local Peer CYNATA THERAPEUTICS LTD ASX 78.473 - - 8.0626 -
Other Local Peers BIOTRON (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), BIONOMICS LTD (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), REGENEUS LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), RHINOMED LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), ANATARA LIFESCIENCES LTD (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Global Peer AMGEN INC NASDAQ 141,474.386 18.041 19.383 13.2728 2.425
Global Peer GILEAD SCIENCES INC NASDAQ 86,313.200 16.025 - 4.7577 3.696
Global Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Global Peer VERTEX PHARMACEUTICAL NASDAQ 71,196.050 60.499 34.216 9.4685 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 66,091.756 31.237 33.506 - -
Global Peer ILLUMINA INC NASDAQ 58,701.510 58.584 62.316 12.6648 -
Global Peer BIOGEN INC NASDAQ 43,957.188 7.465 7.417 3.8870 -
Global Peer WUXI BIO HKEx 228,464.733 198.740 198.739 15.9759 -
Global Peer MODERNA INC NASDAQ 28,679.658 - - - -
Global Peer SEATTLE GENETICS INC NASDAQ 28,152.715 - - 15.5190 -
Other Global Peers SINO BIOPHARM (HKEx), ALEXION PHARMACEUTICAL INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), INCYTE CORPORATION (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NOVAVAX INC (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), Lonza (SGX), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), GENSCRIPT BIO (HKEx), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ALKERMES PLC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), HAOHAI BIOTEC (HKEx), FATE THERAPEUTICS (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VIVA BIOTECH (HKEx), EDITAS MEDICINE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ALPHAMAB-B (HKEx), VIELA BIO INC (NASDAQ), VERACYTE INC (NASDAQ), UNIQURE N.V. (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), VAXCYTE INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), MACROGENICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CYTOKINETICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), HERON THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), COMPUGEN (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), REGENXBIO INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), CORTEXYME INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ALECTOR INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), ARVINAS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), ASCENTAGE-B (HKEx), FRONTAGE (HKEx), MERIDIAN BIOSCIENCE INC COM (NASDAQ), TRANSLATE BIO INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), RETROPHIN INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), OMEROS CORP (NASDAQ), KINTOR PHARMA-B (HKEx), MORPHIC HOLDING INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), IMMUNOGEN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), PERSONALIS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VAXART INC (NASDAQ), AKOUOS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), AVROBIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AGENUS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), GERON CORP (NASDAQ), ATHERSYS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ARDELYX INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DPHARMA (Bursa), ANAPTYSBIO INC (NASDAQ), LEE'S PHARM (HKEx), SINOVAC BIOTECH LTD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), ASCLETIS-B (HKEx), SINOMAB BIO-B (HKEx), XBIOTECH INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), KAMADA (NASDAQ), MERUS B V (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), IBIO INC (NYSE American), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), ESSEX BIO-TECH (HKEx), IVERIC BIO INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), IMV INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CABALETTA BIO INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AFFIMED N V (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), TREVENA INC (NASDAQ), CHIASMA INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VERASTEM INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), XOMA CORP (NASDAQ), PFENEX INC (NYSE American), VTV THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), EQUILLIUM INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), INMUNE BIO INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CONTRAFECT CORP (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), X4 PHARMACEUTICALS INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), LUMOS PHARMA INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), CEL-SCI CORP (NYSE American), CHAMPIONS ONCOLOGY INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), VACCINEX INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SESEN BIO INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), SAVARA INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), UNI-BIO GROUP (HKEx), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), RECRO PHARMA INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), RESTORBIO INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), ARAVIVE INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), ONCOLYTICS BIOTECH INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), CURIS INC (NASDAQ), SYNLOGIC INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), 9 METERS BIOPHARMA INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), OCUGEN INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ORAGENICS INC (NYSE American), PRECIPIO INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CT ENTERPRISE (HKEx), ACHIEVE LIFE SCIENCE INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ATYR PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), BIOCARDIA INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BIOSINO BIO-TEC (HKEx), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), EVOGENE LTD (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), Suntar Eco-City (SGX), ITERUM THERAPEUTICS PLC (NASDAQ), REGENT PACIFIC (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), HAO WEN H-NEW (HKEx), HAO WEN H-OLD (HKEx)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.075
-5.60 %
10 Days --0.105
-7.66 %
20 Days --0.125
-8.99 %
Medium Term Return 3 Months --0.515
-28.93 %
6 Months --1.205
-48.79 %
1 Year --1.685
-57.12 %
Long Term Return 2 Years -+1.110
+716.13 %
3 Years -+1.110
+716.13 %
5 Years -+1.110
+716.13 %
Annualised Return Annualised --
+52.18 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.000 - 3.350 Change From 1 Year Low +0.265 % Change From 1 Year Low (%) +26.50
Change From 1 Year High -2.085 % Change From 1 Year High (%) -62.24
2 Years Range 1.000 - 4.730 Change From 2 Years Low +0.265 % Change From 2 Years Low (%) +26.50
Change From 2 Years High -3.465 % Change From 2 Years High (%) -73.26
5 Years Range 1.000 - 4.730 Change From 5 Years Low +0.265 % Change From 5 Years Low (%) +26.50
Change From 5 Years High -3.465 % Change From 5 Years High (%) -73.26
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Next Science Ltd. engages in the research, development, and distribution of technologies with bacterial issue application. It commercialize proprietary Xbio technology to reduce the impact of biofilm based infections in human health. The company was founded by Matthew Myntti on October 20, 2017 and is headquartered in Chatswood, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
07 Aug 2020 1.275 1.310 1.260 1.265 92,707 -
06 Aug 2020 1.270 1.285 1.255 1.270 111,975 -
05 Aug 2020 1.300 1.300 1.260 1.295 76,585 -
04 Aug 2020 1.325 1.350 1.285 1.295 60,063 -
03 Aug 2020 1.345 1.360 1.270 1.290 120,911 -
31 Jul 2020 1.440 1.440 1.337 1.340 190,726 -
30 Jul 2020 1.370 1.440 1.370 1.440 107,719 -
29 Jul 2020 1.400 1.400 1.370 1.370 113,259 -
28 Jul 2020 1.380 1.400 1.350 1.370 87,459 -
27 Jul 2020 1.400 1.410 1.340 1.360 85,080 -
24 Jul 2020 1.350 1.420 1.315 1.370 219,440 -
23 Jul 2020 1.300 1.350 1.290 1.335 95,434 -
22 Jul 2020 1.310 1.320 1.280 1.300 63,246 -
21 Jul 2020 1.265 1.350 1.265 1.310 243,367 -
20 Jul 2020 1.300 1.300 1.230 1.260 136,491 -
17 Jul 2020 1.320 1.320 1.280 1.280 65,655 -
16 Jul 2020 1.335 1.335 1.300 1.300 96,474 -
15 Jul 2020 1.340 1.400 1.330 1.335 136,381 -
14 Jul 2020 1.370 1.430 1.320 1.330 298,785 -
13 Jul 2020 1.450 1.450 1.355 1.430 158,830 -
10 Jul 2020 1.470 1.485 1.375 1.390 182,745 -
09 Jul 2020 1.490 1.490 1.400 1.410 164,712 -
Summary
Current 2 Weeks
(27 Jul 2020 to 07 Aug 2020)
1.400 1.440 1.255 1.265 1,046,484 -
Previous 2 Weeks
(13 Jul 2020 to 24 Jul 2020)
1.450 1.450 1.255 1.370 1,514,103 -
4 Weeks from
(12 Jun 2020 to 10 Jul 2020)
1.380 1.440 1.255 1.390 5,535,386 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.